Peak aortic blood acceleration: a possible indicator of initial left ventricular impairment in patients with coronary

F Cucchini1, C Di Mario, A Iavernaro

  • 1Division of Cardiology, Ospedale Civile, Bassano del Grappa (VI), Italy.

European Heart Journal
|August 1, 1991
PubMed

Insights

Maximal blood acceleration in the aorta may detect early myocardial impairment in coronary artery disease patients. However, its clinical use is limited by overlapping values and inability to differentiate disease severity.

Area of Science:

  • Cardiology
  • Biomedical Engineering
  • Physiology

Background:

  • Coronary artery disease (CAD) diagnosis often relies on invasive methods.
  • Assessing early left ventricular (LV) dysfunction in CAD is crucial.
  • Conventional hemodynamic indices may not detect subtle myocardial impairment.

Purpose of the Study:

  • To evaluate maximal blood acceleration in the ascending aorta as an indicator of early myocardial impairment.
  • To assess the utility of maximal aortic acceleration in patients with coronary artery disease.
  • To compare aortic acceleration between CAD patients and a control group.

Main Methods:

  • Utilized a catheter-tip electromagnetic velocity transducer in 25 patients.
  • Performed complete hemodynamic evaluation, including pressure recordings and derived indices.
  • Included left ventriculography and coronary angiography for comprehensive assessment.

Main Results:

  • Maximal aortic acceleration was significantly lower in CAD patients (378 +/- 130) compared to controls (562 +/- 82, P < 0.01).
  • This reduction was also observed in CAD patients with normal LV systolic function (310 +/- 102 vs 562 +/- 82, P < 0.01).
  • No correlation found between aortic acceleration and LV peak systolic pressure, +dP/dt, end-systolic volume index, or ejection fraction.

Conclusions:

  • Maximal blood acceleration may detect initial myocardial impairment in CAD patients with preserved conventional LV function.
  • Clinical utility is limited by overlapping values between patient groups.
  • Inability to further stratify ischemic patients based on LV impairment or coronary involvement severity.

Related Concept Videos

Murine Nasal Lavage Fluid Collection without Blood Contamination05:12

Murine Nasal Lavage Fluid Collection without Blood Contamination

The present protocol describes a novel method for avoiding blood contamination in murine nasal lavage fluid (NLF). Since this method ensures the NLF collection without blood contamination, it allows for more accurate detections of immunological components and various respiratory...
1.7K
Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome03:40

Nasolacrimal Lavage as a Treatment for Ocular Surface Toxic Soup Syndrome

OSTSS leads to pooled inflammatory mediators in the tear film, causing symptoms like epiphora and discomfort. Here, we present a case where therapeutic nasolacrimal lavage every 2 months resolved epiphora and itchiness, suggesting its efficacy as a therapeutic intervention for OSTSS. Additionally, we report subjective improvements in symptoms in 3 additional...
1.1K
Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment04:35

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment

Saline nasal lavage can be used to sample the canine nasal immune microenvironment. Because the approach is relatively non-invasive and does not disrupt the nasal tissues, it can be performed serially. Cells and proteins collected from the nasal lavage technique can be processed for various laboratory analyses.
880
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

A protocol for conducting a challenge in an allergen exposure chamber (AEC) facility is presented. AECs have proven to be safe and effective tools for the induction of allergic symptoms or as an endpoint in the efficacy testing of allergen immunotherapy due to their ability to maintain stable particle concentrations and environmental...
2.9K
Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Batrachochytrium dendrobatidis infection in amphibians can be eliminated using a reduced concentration (0.0025%) and shorter duration (five minute baths for six days) of itraconazole than is generally used. Less mortality and fewer negative side effects were observed using this modified treatment...
12.0K
Intranasal Administration of CNS Therapeutics to Awake Mice07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

A method to intranasally administer drugs to awake mice for the purpose of targeting the brain is described. This method allows for repeat dosing over long periods using intranasal administration of drug without anesthesia, and nose-to-brain delivery with minimal systemic...
61.4K